7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway (Cancer Chemotherapy and Pharmacology DOI: 10.1007/s00280-007-0667-5);7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway

Cancer Chemotherapy and Pharmacology

Volumn 62, Issue 5, 2008, Pages 799-808

  Hsu, Tzu Sheng ^a   Chen, Chinpiao ^b   Lee, Pei Ting ^b   Chiu, Shu Jun ^a   Liu, Huei Fang ^a   Tsai, Chih Chien ^a   Chao, Jui I ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b NATIONAL DONG HWA UNIVERSITY   (Taiwan)

Author keywords

5,8 quinolinedione; Apoptosis; CDC2; ERK; p53; PT 262

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 6 ANILINO 5,8 QUINOLINEQUINONE; 7 CHLORO 6 PIPERIDIN 1 YL QUINOLINE 5,8 DIONE; CASPASE; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; NSC 663284; PROTEIN P35; PT 262; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 49749120269     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0718-6     Document Type: Erratum

References (36)

1. E Yoon HY Choi KJ Shin KH Yoo DI Chi DJ Kim 2000 The regioselectivity in the reaction of 6,7-dihaloquinoline-5,8-diones with amine nucleophiles in various solvents Tetrahedron Lett 41 7475 7480
2. DL Boger M Yasuda LA Mitscher SD Drake PA Kitos SC Thompson 1987 Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones J Med Chem 30 1918 1928
3. L Pu AA Amoscato ME Bier JS Lazo 2002 Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 7-chloro-6-(2-morpholin-4-ylethylamino)- quinoline-5,8-dione J Biol Chem 277 46877 46885
4. Y Fang CM Linardic DA Richardson W Cai M Behforouz RT Abraham 2003 Characterization of the cytotoxic activities of novel analogues of the antitumor agent, lavendamycin Mol Cancer Ther 2 517 526
5. YS Lee RD Wurster 1995 Mechanism of potentiation of LY83583-induced growth inhibition by sodium nitroprusside in human brain tumor cells Cancer Chemother Pharmacol 36 341 344
6. D Lodygin A Menssen H Hermeking 2002 Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner J Clin Invest 110 1717 1727
7. JS Lazo DC Aslan EC Southwick KA Cooley AP Ducruet B Joo A Vogt P Wipf 2001 Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25 J Med Chem 44 4042 4049
8. NR Wall DS O'Connor J Plescia Y Pommier DC Altieri 2003 Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis Cancer Res 63 230 235
9. K Tamura EC Southwick J Kerns K Rosi BI Carr C Wilcox JS Lazo 2000 Cdc25 inhibition and cell cycle arrest by a synthetic thioalkyl vitamin K analogue Cancer Res 60 1317 1325
10. CC Kuo HP Hsieh WY Pan CP Chen JP Liou SJ Lee YL Chang LT Chen CT Chen JY Chang 2004 BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo Cancer Res 64 4621 4628
11. AJ Waskiewicz JA Cooper 1995 Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast Curr Opin Cell Biol 7 798 805
12. SJ Mansour WT Matten AS Hermann JM Candia S Rong K Fukasawa GF Vande Woude NG Ahn 1994 Transformation of mammalian cells by constitutively active MAP kinase kinase Science 265 966 970
13. R Marais CJ Marshall 1996 Control of the ERK MAP kinase cascade by Ras and Raf Cancer Surv 27 101 125
14. RS Sawhney MM Cookson Y Omar J Hauser MG Brattain 2006 Integrin alpha2-mediated ERK and calpain activation play a critical role in cell adhesion and motility via focal adhesion kinase signaling: identification of a novel signaling pathway J Biol Chem 281 8497 8510
15. S Bates KH Vousden 1996 p53 in signaling checkpoint arrest or apoptosis Curr Opin Genet Dev 6 12 18
16. AJ Levine 1997 p53, the cellular gatekeeper for growth and division Cell 88 323 331
17. LJ Hofseth SP Hussain CC Harris 2004 p53: 25 years after its discovery Trends Pharmacol Sci 25 177 181
18. C Brantley-Finley CS Lyle L Du ME Goodwin T Hall D Szwedo GP Kaushal TC Chambers 2003 The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide Biochem Pharmacol 66 459 469
19. W Piao J Yoo DK Lee HJ Hwang JH Kim 2001 Induction of G(2)/M phase arrest and apoptosis by a new synthetic anti-cancer agent, DW2282, in promyelocytic leukemia (HL-60) cells Biochem Pharmacol 62 1439 1447
20. JI Chao PC Kuo TS Hsu 2004 Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells J Biol Chem 279 20267 20276
21. F Fang JW Newport 1991 Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes Cell 66 731 742
22. RW King PK Jackson MW Kirschner 1994 Mitosis in transition Cell 79 563 571
23. Z Han D Chatterjee DM He J Early P Pantazis JH Wyche EA Hendrickson 1995 Evidence for a G2 checkpoint in p53-independent apoptosis induction by X-irradiation Mol Cell Biol 15 5849 5857
24. RB Lock WE Ross 1990 Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells Cancer Res 50 3761 3766
25. MA Jordan RJ Toso D Thrower L Wilson 1993 Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations Proc Natl Acad Sci USA 90 9552 9556
26. PC Kuo HF Liu JI Chao 2004 Survivin and p53 modulate quercetin-induced cell growth inhibition and apoptosis in human lung carcinoma cells J Biol Chem 279 55875 55885
27. YH Ling Y Yang C Tornos B Singh R Perez-Soler 1998 Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells Cancer Res 58 3633 3640
28. RW Johnstone AA Ruefli SW Lowe 2002 Apoptosis: a link between cancer genetics and chemotherapy Cell 108 153 164
29. SW Wijnhoven E Sonneveld HJ Kool CM van Teijlingen H Vrieling 2003 Chemical carcinogens induce varying patterns of LOH in mouse T-lymphocytes Carcinogenesis 24 139 144
30. JS Isenberg JE Klaunig 2000 Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells Toxicol Sci 53 340 351
31. J Pines 1999 Cell cycle. Checkpoint on the nuclear frontier Nature 397 104 105
32. TW Gant DN Rao RP Mason GM Cohen 1988 Redox cycling and sulphydryl arylation; their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytes Chem Biol Interact 65 157 173
33. D Ross H Thor S Orrenius P Moldeus 1985 Interaction of menadione (2-methyl-1,4-naphthoquinone) with glutathione Chem Biol Interact 55 177 184
34. L Rossi GA Moore S Orrenius PJ O'Brien 1986 Quinone toxicity in hepatocytes without oxidative stress Arch Biochem Biophys 251 25 35
35. I Wilson P Wardman TS Lin AC Sartorelli 1987 Reactivity of thiols towards derivatives of 2- and 6-methyl-1,4-naphthoquinone bioreductive alkylating agents Chem Biol Interact 61 229 240
36. C Chen YZ Liu KS Shia HY Tseng 2002 Synthesis and anticancer evaluation of vitamin K3 analogues Bioorg Med Chem Lett 12 2729 2732